ArticleProtein engineering, design & selection : PEDS2026
Targeted mutagenesis of a thermophilic mevalonate kinase for efficient catalysis at lower temperatures.
Article in Protein engineering, design & selection : PEDS, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
Thermophile-derived enzymes are of interest for cell-free biocatalysis due to their intrinsic thermostability, which simplifies purification via heat treatment and correlates with enhanced activity retention under cell-free reaction conditions. However, thermal stability often comes at the expense of slower turnover rates for reactions that need to be conducted at ambient temperature out of concern for cofactor stability and to reduce energy requirements. This study demonstrates a targeted engineering strategy to increase the room temperature activity of the thermophilic mevalonate kinase from Methanocaldococcus jannaschii. Site-saturation mutagenesis of evolutionarily variable residues within the mevalonate binding pocket generated numerous mutants with increased activity at 22°C. Fifteen mutants demonstrated a two- to four-fold increase in activity, and the most active mutant, I10S, achieved a five-fold increase in kcat relative to the wild-type. Importantly, the I10S mutant retained thermostability comparable to the wild-type, and a minimal decline in long-term stability was observed. This mutagenesis strategy may have broader applications towards tuning thermophilic enzyme activity at desired operating temperatures to enhance the efficiency of cell-free reactions while reducing operating costs.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.